Comerica Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $13.4M | Sell |
17,340
-350
| -2% | -$238K | 0.05% | 288 |
|
|
2025
Q3 | $9.95M | Buy |
17,690
+2,783
| +19% | +$1.57M | 0.04% | 431 |
|
|
2025
Q2 | $7.83M | Sell |
14,907
-69
| -0.5% | -$38.5K | 0.03% | 507 |
|
|
2025
Q1 | $9.5M | Buy |
14,976
+789
| +6% | +$543K | 0.04% | 418 |
|
|
2024
Q4 | $10.1M | Sell |
14,187
-1,364
| -9% | -$1.14M | 0.04% | 411 |
|
|
2024
Q3 | $16.3M | Buy |
15,551
+191
| +1% | +$213K | 0.06% | 299 |
|
|
2024
Q2 | $16.1M | Buy |
15,360
+54
| +0.4% | +$52.3K | 0.07% | 276 |
|
|
2024
Q1 | $14.7M | Sell |
15,306
-363
| -2% | -$345K | 0.06% | 305 |
|
|
2023
Q4 | $13.8M | Sell |
15,669
-637
| -4% | -$525K | 0.06% | 306 |
|
|
2023
Q3 | $13.4M | Sell |
16,306
-5,863
| -26% | -$4.61M | 0.07% | 269 |
|
|
2023
Q2 | $1 | Buy |
+22,169
| New | +$17.1M | ﹤0.01% | 687 |
|
|
2022
Q4 | $9.99M | Sell |
13,718
-427
| -3% | -$315K | 0.08% | 277 |
|
|
2022
Q3 | $10.4M | Sell |
14,145
-235
| -2% | -$148K | 0.09% | 228 |
|
|
2022
Q2 | $8.57M | Buy |
14,380
+167
| +1% | +$109K | 0.07% | 301 |
|
|
2022
Q1 | $10.2M | Sell |
14,213
-312
| -2% | -$197K | 0.07% | 273 |
|
|
2021
Q4 | $8.76M | Sell |
14,525
-212
| -1% | -$130K | 0.06% | 314 |
|
|
2021
Q3 | $8.44M | Sell |
14,737
-4,276
| -22% | -$2.65M | 0.05% | 412 |
|
|
2021
Q2 | $12.5M | Sell |
19,013
-1,178
| -6% | -$597K | 0.07% | 257 |
|
|
2021
Q1 | $9.87M | Sell |
20,191
-378
| -2% | -$184K | 0.06% | 363 |
|
|
2020
Q4 | $11.1M | Buy |
20,569
+975
| +5% | +$526K | 0.07% | 289 |
|
|
2020
Q3 | $11.4M | Buy |
19,594
+913
| +5% | +$554K | 0.08% | 233 |
|
|
2020
Q2 | $11.9M | Buy |
18,681
+3,483
| +23% | +$1.98M | 0.09% | 205 |
|
|
2020
Q1 | $8.61M | Sell |
15,198
-387
| -2% | -$160K | 0.08% | 240 |
|
|
2019
Q4 | $5.24M | Sell |
15,585
-295
| -2% | -$99.3K | 0.04% | 508 |
|
|
2019
Q3 | $4.86M | Buy |
15,880
+736
| +5% | +$218K | 0.04% | 523 |
|
|
2019
Q2 | $4.54M | Sell |
15,144
-117
| -0.8% | -$39K | 0.04% | 569 |
|
|
2019
Q1 | $6.23M | Sell |
15,261
-14,685
| -49% | -$6.05M | 0.05% | 410 |
|
|
2018
Q4 | $12.5M | Sell |
29,946
-5,379
| -15% | -$1.97M | 0.11% | 186 |
|
|
2018
Q3 | $13.4M | Sell |
35,325
-4,391
| -11% | -$1.67M | 0.11% | 181 |
|
|
2018
Q2 | $14.5M | Buy |
39,716
+24
| +0.1% | +$7.51K | 0.1% | 195 |
|
|
2018
Q1 | $12.5M | Buy |
39,692
+2,819
| +8% | +$980K | 0.09% | 236 |
|
|
2017
Q4 | $14.1M | Buy |
36,873
+5,518
| +18% | +$2.23M | 0.09% | 209 |
|
|
2017
Q3 | $12.7M | Buy |
31,355
+810
| +3% | +$385K | 0.09% | 210 |
|
|
2017
Q2 | $15.9M | Sell |
30,545
-159
| -0.5% | -$69.6K | 0.12% | 159 |
|
|
2017
Q1 | $11.3M | Buy |
30,704
+714
| +2% | +$265K | 0.09% | 232 |
|
|
2016
Q4 | $11M | Buy |
29,990
+1,831
| +7% | +$696K | 0.09% | 230 |
|
|
2016
Q3 | $10.9M | Buy |
28,159
+5,961
| +27% | +$2.39M | 0.09% | 208 |
|
|
2016
Q2 | $9.31M | Sell |
22,198
-981
| -4% | -$378K | 0.08% | 241 |
|
|
2016
Q1 | $9.43M | Sell |
23,179
-1,098
| -5% | -$452K | 0.08% | 224 |
|
|
2015
Q4 | $11.9M | Buy |
24,277
+869
| +4% | +$471K | 0.12% | 166 |
|
|
2015
Q3 | $10.9M | Sell |
23,408
-23,208
| -50% | -$12.5M | 0.1% | 182 |
|
|
2015
Q2 | $23.8M | Buy |
46,616
+23,063
| +98% | +$11.3M | 0.1% | 189 |
|
|
2015
Q1 | $10.6M | Sell |
23,553
-15,957
| -40% | -$6.76M | 0.09% | 212 |
|
|
2014
Q4 | $16.2M | Buy |
39,510
+19,591
| +98% | +$7.7M | 0.07% | 277 |
|
|
2014
Q3 | $7.18M | Sell |
19,919
-2,793
| -12% | -$936K | 0.06% | 304 |
|
|
2014
Q2 | $6.42M | Sell |
22,712
-7,749
| -25% | -$2.3M | 0.05% | 357 |
|
|
2014
Q1 | $9.15M | Buy |
30,461
+247
| +0.8% | +$76.1K | 0.07% | 267 |
|
|
2013
Q4 | $8.32M | Sell |
30,214
-754
| -2% | -$217K | 0.06% | 288 |
|
|
2013
Q3 | $9.69M | Buy |
30,968
+893
| +3% | +$235K | 0.07% | 280 |
|
|
2013
Q2 | $6.76M | Buy |
+30,075
| New | +$7M | 0.06% | 355 |
|
Other funds holding REGN
N
Comerica Bank's REGN Position: Q4 2025 in Review
Comerica Bank reduced its Regeneron Pharmaceuticals (REGN) stake by 2% in Q4 2025, selling an estimated $238K and leaving 17,340 shares worth $13.4M. The position accounts for 0.05% of the portfolio, ranked #288.
Comerica Bank first reported a position in REGN in Q2 2013 and has held it in 50 quarters since. The position peaked at $23.8M in Q2 2015. 1,386 funds tracked by Wall St. Rank hold REGN as of Q4 2025.
- Comerica Bank held 17,340 shares of Regeneron Pharmaceuticals worth $13.4M as of Q4 2025.
- Comerica Bank sold 350 Regeneron Pharmaceuticals shares in Q4 2025, an estimated $238K.
- Regeneron Pharmaceuticals made up 0.05% of Comerica Bank's portfolio in Q4 2025, its #288 holding.
- Comerica Bank first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 50 quarters since.
- Comerica Bank's Regeneron Pharmaceuticals position peaked at $23.8M in Q2 2015.
- 1,386 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.
Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.